MEPSGEN CEO YongTae Kim says organ-on-chips will change the clinical paradigm by overcoming the limitations of animal testing.
2025-01-08
Mepsgen raises $14.9 million in series C funding, expands global reach
2024-11-19
NanoCalibur™ to Lead Innovation in Nanomedicine, CEO YongTae Kim Says
2024-10-24
Mepsgen launches automated nanoparticle production equipment ‘NanoCalibur’
2024-10-22
MEPSGEN Receives ￦5.6 Billion Research Grant from MOTIE
2024-08-06
Modeling of Human Organ Tissue Barrier on Organ-on-a-Chip
2024-07-22
MEPSGEN showcases ProMEPS, NanoCalibur at BIO International Convention 2024
2024-06-03
MEPSGEN showcases ProMEPS™ at BIO KOREA 2024
2024-05-02
MEPSGEN Attends 2024 HANKYUNG BIO INSIGHT FORUM
2024-03-11
MEPSGEN Attends 2024 JPMHC
2024-01-12
MEPSGEN Launched ProMEPS _ Automated MPS Modeling System
2023-12-07
MEPSGEN received Commendation from Minister of TIE
MEPSGEN unveils the world's first "Automatic Incubator" for MPS
2023-11-27
Save the animals from dying in labs… first auto-culture device from MEPSGEN
MEPSGEN is attending the 2023 Korean BioChip Society Fall Conference in Jeju, November 15-17.
2023-11-14
Korea-Japan Pharma-Bio Exchange Boosted by Behind the Scenes Efforts
2023-10-16
[BIO JAPAN 2023] MEPSGEN's participation in BIO JAPAN
2023-10-06
“신약개발, 똑똑하게 뭉치자” 연합전선 새 판 짜는 K제약바이오
2023-09-26
MEPSGEN plans to IPO in 2025
2023-09-25
MEPS-AMS is the answer to the rapid advancement of MPS
